<DOC>
	<DOCNO>NCT00256685</DOCNO>
	<brief_summary>The purpose study assess safety efficacy desvenlafaxine succinate ( DVS ) treatment moderate severe vasomotor symptom ( VMS ) associate menopause , also assess effect DVS sleep parameter health outcome indicator .</brief_summary>
	<brief_title>Study Evaluating DVS-233 SR Treat Vasomotor Systems Associated With Menopause</brief_title>
	<detailed_description />
	<mesh_term>Hot Flashes</mesh_term>
	<mesh_term>Sleep Wake Disorders</mesh_term>
	<mesh_term>Parasomnias</mesh_term>
	<criteria>Generally healthy , postmenopausal woman seek treatment hot flush Minimum 7 moderate severe hot flush per day 50 per week record 7 consecutive day screen Body Mass Index ( BMI ) less equal 40 kg/m2 Other inclusion apply . Hypersensitivity Venlafaxine History seizure disorder History myocardial infarction unstable angina within 6 month Other exclusion apply .</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2006</verification_date>
	<keyword>Menopause</keyword>
</DOC>